Φορτώνει......
Absence of GluD2 Antibodies in Patients With Opsoclonus-Myoclonus Syndrome
OBJECTIVE: A recent study showed glutamate receptor delta 2 antibodies (GluD2-ab) in sera of patients with opsoclonus-myoclonus syndrome (OMS). Inconsistencies between cerebellar immunoreactivity and expression of GluD2 led us to hypothesize that these antibodies are not biomarkers of OMS. METHODS:...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Neurology |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Lippincott Williams & Wilkins
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8055333/ https://ncbi.nlm.nih.gov/pubmed/33443132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000011410 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|